CYTK
Price
$60.16
Change
-$0.48 (-0.79%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
7.26B
23 days until earnings call
OLMA
Price
$10.45
Change
-$0.62 (-5.61%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
759.1M
35 days until earnings call
Interact to see
Advertisement

CYTK vs OLMA

Header iconCYTK vs OLMA Comparison
Open Charts CYTK vs OLMABanner chart's image
Cytokinetics
Price$60.16
Change-$0.48 (-0.79%)
Volume$20.85K
Capitalization7.26B
Olema Pharmaceuticals
Price$10.45
Change-$0.62 (-5.61%)
Volume$29.2K
Capitalization759.1M
CYTK vs OLMA Comparison Chart in %
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. OLMA commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Buy and OLMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (CYTK: $60.64 vs. OLMA: $11.06)
Brand notoriety: CYTK and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 120% vs. OLMA: 116%
Market capitalization -- CYTK: $7.26B vs. OLMA: $759.1M
CYTK [@Biotechnology] is valued at $7.26B. OLMA’s [@Biotechnology] market capitalization is $759.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CYTK and OLMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while OLMA’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 4 bearish.
  • OLMA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both CYTK and OLMA are a good buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а +12.53% price change this week, while OLMA (@Biotechnology) price change was +15.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was +16.24%, and the average quarterly price growth was +90.12%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

OLMA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($7.26B) has a higher market cap than OLMA($759M). OLMA YTD gains are higher at: 89.708 vs. CYTK (28.912). OLMA has higher annual earnings (EBITDA): -156.66M vs. CYTK (-504.83M). CYTK has more cash in the bank: 858M vs. OLMA (362M). OLMA has less debt than CYTK: OLMA (4.76M) vs CYTK (858M). CYTK has higher revenues than OLMA: CYTK (85.7M) vs OLMA (0).
CYTKOLMACYTK / OLMA
Capitalization7.26B759M956%
EBITDA-504.83M-156.66M322%
Gain YTD28.91289.70832%
P/E RatioN/AN/A-
Revenue85.7M0-
Total Cash858M362M237%
Total Debt858M4.76M18,044%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKOLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CWGCX75.170.04
+0.05%
American Funds Capital World Gr&Inc C
MDDAX8.18N/A
N/A
MassMutual Diversified Value A
JSVZX25.95N/A
N/A
JPMorgan Small Cap Value R2
ALAFX112.20N/A
N/A
Alger Focus Equity A
HEOIX18.50N/A
N/A
Hartford Climate Opportunities I

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-0.36%
IDYA - OLMA
46%
Loosely correlated
-0.54%
ATXS - OLMA
45%
Loosely correlated
+2.26%
CRNX - OLMA
45%
Loosely correlated
+2.01%
CYTK - OLMA
43%
Loosely correlated
+6.44%
IPSC - OLMA
42%
Loosely correlated
+8.18%
More